Page 48 - Read Online

Weidner et al. J Transl Genet Genom 2019;3:2. I https://doi.org/10.20517/jtgg.2018.30 Page 13 of 16

18. Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 2019;20:21-37.
19. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol
(Lausanne) 2018;9:402.
20. Callari M, Tiberio P, De Cecco L, Cavadini E, Dugo M, et al. Feasibility of circulating miRNA microarray analysis from archival plasma
samples. Anal Biochem 2013;437:123-5.
21. Ge Q, Zhou Y, Lu J, Bai Y, Xie X, et al. miRNA in plasma exosome is stable under different storage conditions. Molecules 2014;19:1568-75.
22. Grasedieck S, Sorrentino A, Langer C, Buske C, Döhner H, et al. Circulating microRNAs in hematological diseases: principles, challenges,
and perspectives. Blood 2013;121:4977-84.
23. Mraz M, Malinova K, Mayer J, Pospisilova S. MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun
2009;390:1-4.
24. Grasedieck S, Schöler N, Bommer M, Niess JH, Tumani H, et al. Impact of serum storage conditions on microRNA stability. Leukemia
2012;26:2414-6.
25. Lloyd CM. Building better mouse models of asthma. Curr Allergy Asthma Rep 2007;7:231-6.
26. Rosenberg HF, Druey KM. Modeling asthma: pitfalls, promises, and the road ahead. J Leukoc Biol 2018;104:41-8.
27. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, et al. Attenuation of allergic airway inflammation in IL-4 deficient
mice. Clin Exp Allergy 1994;24:73-80.
28. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, et al. Continuous exposure to house dust mite elicits chronic airway
inflammation and structural remodeling. Am J Respir Crit Care Med 2004;169:378-85.
29. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol 2015;15:271-82.
30. Halim TY, Krauss RH, Sun AC, Takei F. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-
induced airway inflammation. Immunity 2012;36:451-63.
31. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-
1(+) lymphoid cells. Nature 2010;463:540-4.
32. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.
Nature 2010;464:1367-70.
33. Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol
2005;6:R71.
34. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement
of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 2011;12:796-803.
35. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A, et al. Aberrant T cell differentiation in the absence of Dicer. J Exp Med
2005;202:261-9.
36. Cho S, Wu CJ, Yasuda T, Cruz LO, Khan AA, et al. miR-23~ 27~24 clusters control effector T cell differentiation and function. J Exp Med
2016;213:235-49.
37. Pua HH, Steiner DF, Patel S, Gonzalez JR, Ortiz-Carpena JF, et al. MicroRNAs 24 and 27 suppress allergic inflammation and target a
network of regulators of T Helper 2 cell-associated cytokine production. Immunity 2016;44:821-32.
38. Okoye IS, Czieso S, Ktistaki E, Roderick K, Coomes SM, et al. Transcriptomics identified a critical role for Th2 cell-intrinsic miR-155 in
mediating allergy and antihelminth immunity. Proc Natl Acad Sci U S A 2014;111:E3081-90.
39. Jiménez-Morales S, Gamboa-Becerra R, Baca V, Del Río-Navarro BE, López-Ley DY, et al. MiR-146a polymorphism is associated with
asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients. Tissue Antigens 2012;80:317-21.
40. Polikepahad S, Knight JM, Naghavi AO, Oplt T, Creighton CJ, et al. Proinflammatory role for let-7 microRNAS in experimental asthma. J
Biol Chem 2010;285:30139-49.
41. Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, et al. Let-7 microRNA-mediated regulation of IL-13 and allergic airway
inflammation. J Allergy Clin Immunol 2011;128:1077-85.
42. Vigorito E, Kohlhaas S, Lu D, Leyland R. miR-155: an ancient regulator of the immune system. Immunol Rev 2013;253:146-57.
43. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. Requirement of bic/microRNA-155 for normal immune function. Science
2007;316:608-11.
44. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, et al. Regulation of the germinal center response by microRNA-155. Science
2007;316:604-8.
45. Johansson K, Malmhäll C, Ramos-Ramírez P, Rådinger M, et al. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and
IL-33 signaling in experimental models of allergic airway inflammation. J Allergy Clin Immunol 2017;139:1007-16.
46. Malmhäll C, Alawieh S, Lu Y, Sjöstrand M, Bossios A, et al. MicroRNA-155 is essential for T(H)2-mediated allergen-induced eosinophilic
inflammation in the lung. J Allergy Clin Immunol 2014;133:1429-38.
47. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/
IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol 2011;187:3362-73.
48. Divekar R, Kita H. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic
inflammation. Curr Opin Allergy Clin Immunol 2015;15:98-103.
49. McKenzie ANJ, Spits H, Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity 2014;41:366-74.
50. Christianson CA, Goplen NP, Zafar I, Irvin C, Good JT Jr, et al. Persistence of asthma requires multiple feedback circuits involving type 2
innate lymphoid cells and IL-33. J Allergy Clin Immunol 2015;136:59-68.
51. Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, et al. Increased numbers of activated group 2 innate lymphoid cells in the airways